東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Chronic lymphocytic leukemia

Hallek, Michael.

FindBook

Google Book

Amazon

博客來

Chronic lymphocytic leukemia

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Chronic lymphocytic leukemia/ edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky.
其他作者:	Hallek, Michael.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	vi, 179 p. :ill., digital ;24 cm.
內容註:	Pathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities.
Contained By:	Springer eBooks
標題:	Chronic lymphocytic leukemia. -
電子資源:	https://doi.org/10.1007/978-3-030-11392-6
ISBN:	9783030113926

Chronic lymphocytic leukemia
Chronic lymphocytic leukemia[electronic resource] /edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky. - Cham :Springer International Publishing :2019. - vi, 179 p. :ill., digital ;24 cm. - Hematologic malignancies,2197-9766. - Hematologic malignancies..

Pathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities.

This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed.

ISBN: 9783030113926

Standard No.: 10.1007/978-3-030-11392-6doiSubjects--Topical Terms:

1359780
Chronic lymphocytic leukemia.

LC Class. No.: RC643 / .C47 2019

Dewey Class. No.: 616.99419

Chronic lymphocytic leukemia
LDR:02287nmm a2200337 a 4500 001 2190627
003 DE-He213
005 20190424194549.0
006 m d
007 cr nn 008maaau
008 200501s2019 gw s 0 eng d
020 $a 9783030113926 $q (electronic bk.)
020 $a 9783030113919 $q (paper)
024 7 $a 10.1007/978-3-030-11392-6 $2 doi
035 $a 978-3-030-11392-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC643 $b .C47 2019
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.99419 $2 23
090 $a RC643 $b .C557 2019
245 0 0 $a Chronic lymphocytic leukemia $h [electronic resource] / $c edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a vi, 179 p. : $b ill., digital ; $c 24 cm.
490 1 $a Hematologic malignancies, $x 2197-9766
505 0 $a Pathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities.
520 $a This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed.
650 0 $a Chronic lymphocytic leukemia. $3 1359780
650 1 4 $a Hematology. $3 808260
650 2 4 $a Oncology. $3 751006
700 1 $a Hallek, Michael. $3 3409285
700 1 $a Eichhorst, Barbara. $3 3409286
700 1 $a Catovsky, Daniel. $3 3409287
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Hematologic malignancies. $3 1568109
856 4 0 $u https://doi.org/10.1007/978-3-030-11392-6
950 $a Medicine (Springer-11650)